Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of INKA2 mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of FAM212B mRNA | CTD | PMID:28960355 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of INKA2 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of INKA2 mRNA | CTD | PMID:33387578 | 5-aza-2'-deoxycytidine | affects expression | ISO | INKA2 (Homo sapiens) | 6480464 | Decitabine affects the expression of INKA2 mRNA | CTD | PMID:23300844 | 5-fluorouracil | multiple interactions | ISO | INKA2 (Homo sapiens) | 6480464 | TP53 protein affects the reaction [Fluorouracil results in increased expression of INKA2 mRNA] | CTD | PMID:15016801 | 6-propyl-2-thiouracil | decreases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of INKA2 mRNA | CTD | PMID:24780913 | acetamide | increases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of INKA2 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of INKA2 mRNA | CTD | PMID:21641981 and PMID:32234424 | amiodarone | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | Amiodarone results in increased expression of INKA2 mRNA | CTD | PMID:19774075 | arsane | affects methylation | ISO | INKA2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of INKA2 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | INKA2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of INKA2 gene | CTD | PMID:25304211 | benzo[a]pyrene | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of INKA2 mRNA | CTD | PMID:20106945 more ... | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of INKA2 mRNA | CTD | PMID:32417428 | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of INKA2 mRNA | CTD | PMID:27858113 | benzo[a]pyrene | affects methylation | ISO | INKA2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of INKA2 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 | benzo[b]fluoranthene | increases expression | EXP | | 6480464 | benzo(b)fluoranthene results in increased expression of INKA2 mRNA | CTD | PMID:26377693 | benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of INKA2 mRNA | CTD | PMID:27858113 | bisphenol A | decreases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of INKA2 mRNA | CTD | PMID:25181051 more ... | bisphenol A | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of INKA2 mRNA | CTD | PMID:29275510 | bisphenol A | increases methylation | ISO | Inka2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of INKA2 gene | CTD | PMID:28505145 | bisphenol F | decreases expression | EXP | | 6480464 | bisphenol F results in decreased expression of FAM212B mRNA | CTD | PMID:30951980 | cadmium atom | multiple interactions | ISO | INKA2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INKA2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | INKA2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INKA2 mRNA | CTD | PMID:35301059 | cantharidin | decreases expression | EXP | | 6480464 | Cantharidin results in decreased expression of INKA2 mRNA | CTD | PMID:36907384 | chlordecone | increases expression | EXP | | 6480464 | Chlordecone results in increased expression of INKA2 mRNA | CTD | PMID:33711761 | chrysene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of INKA2 mRNA | CTD | PMID:27858113 | cidofovir anhydrous | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | Cidofovir results in increased expression of INKA2 mRNA | CTD | PMID:25596134 | cisplatin | affects expression | ISO | INKA2 (Homo sapiens) | 6480464 | Cisplatin affects the expression of INKA2 mRNA | CTD | PMID:23300844 | cisplatin | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of INKA2 mRNA | CTD | PMID:21532991 more ... | copper atom | increases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Copper results in increased expression of FAM212B mRNA | CTD | PMID:30556269 | copper(0) | increases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Copper results in increased expression of FAM212B mRNA | CTD | PMID:30556269 | copper(II) sulfate | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of INKA2 mRNA | CTD | PMID:19549813 | dibenz[a,h]anthracene | increases expression | EXP | | 6480464 | 1 more ... | CTD | PMID:26377693 | diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of FAM212B mRNA | CTD | PMID:35537566 | doxorubicin | affects methylation | ISO | Inka2 (Rattus norvegicus) | 6480464 | Doxorubicin affects the methylation of INKA2 gene | CTD | PMID:28962528 | endosulfan | decreases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of INKA2 mRNA | CTD | PMID:29391264 | etoposide | increases expression | EXP | | 6480464 | Etoposide results in increased expression of INKA2 mRNA | CTD | PMID:25270620 | fluoranthene | multiple interactions | EXP | | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of INKA2 mRNA | CTD | PMID:28329830 | furan | increases methylation | ISO | Inka2 (Rattus norvegicus) | 6480464 | furan results in increased methylation of INKA2 gene | CTD | PMID:22079235 | gentamycin | decreases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of INKA2 mRNA | CTD | PMID:33387578 | ifosfamide | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | Ifosfamide results in increased expression of INKA2 mRNA | CTD | PMID:25596134 | iron dichloride | decreases expression | ISO | INKA2 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of INKA2 mRNA | CTD | PMID:35984750 | maneb | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of FAM212B mRNA | CTD | PMID:36117858 | mitomycin C | increases expression | EXP | | 6480464 | Mitomycin results in increased expression of INKA2 mRNA | CTD | PMID:25270620 | N-Nitrosopyrrolidine | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in increased expression of INKA2 mRNA | CTD | PMID:32234424 | O-methyleugenol | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | methyleugenol results in increased expression of INKA2 mRNA | CTD | PMID:32234424 | ozone | decreases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Ozone results in decreased expression of INKA2 mRNA | CTD | PMID:31397875 | paracetamol | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of INKA2 mRNA | CTD | PMID:22230336 and PMID:29067470 | paracetamol | increases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of INKA2 mRNA | CTD | PMID:33387578 | paraquat | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of FAM212B mRNA | CTD | PMID:36117858 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of INKA2 mRNA | CTD | PMID:36331819 | quercetin | increases expression | ISO | INKA2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of INKA2 mRNA | CTD | PMID:21632981 | sodium arsenite | multiple interactions | ISO | INKA2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of and affects the splicing of INKA2 mRNA | CTD | PMID:25879800 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of INKA2 mRNA | CTD | PMID:37682722 | Soman | decreases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of INKA2 mRNA | CTD | PMID:19281266 | tetraphene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of INKA2 mRNA | CTD | PMID:27858113 | trichloroethene | decreases expression | ISO | Inka2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of INKA2 mRNA | CTD | PMID:33387578 | Triptolide | increases expression | EXP | | 6480464 | triptolide results in increased expression of FAM212B mRNA | CTD | PMID:32835833 | triptonide | increases expression | EXP | | 6480464 | triptonide results in increased expression of INKA2 mRNA | CTD | PMID:33045310 | trovafloxacin | increases expression | EXP | | 6480464 | trovafloxacin results in increased expression of FAM212B mRNA | CTD | PMID:35537566 | |